Universal Clinical Codes & Terminology Search

Sacroiliac joint stabilization for arthrodesis percutaneous or minimally invasive (indirect visualization) includes obtaining and applying autograft or allograft (structural or morselized) when performed includes image guidance when performed (eg CT or fluoroscopic)

Oncology (solid organ) targeted genomic sequence analysis formalin-fixed paraffin-embedded (FFPE) tumor tissue DNA analysis 84 or more genes interrogation for sequence variants gene copy number amplifications gene rearrangements microsatellite instability and tumor mutational burden

Extra-osseous subtalar joint implant for talotarsal stabilization

Rare diseases (constitutional/heritable disorders) whole genome sequence analysis including small sequence changes copy number variants deletions duplications mobile element insertions uniparental disomy (UPD) inversions aneuploidy mitochondrial genome sequence analysis with heteroplasmy and large deletions short tandem repeat (STR) gene expansions fetal sample identification and categorization of genetic variants

Laparoscopy surgical ablation of uterine fibroid(s) including intraoperative ultrasound guidance and monitoring radiofrequency

Rare diseases (constitutional/heritable disorders) whole genome sequence analysis including small sequence changes copy number variants deletions duplications mobile element insertions uniparental disomy (UPD) inversions aneuploidy mitochondrial genome sequence analysis with heteroplasmy and large deletions short tandem repeat (STR) gene expansions blood or saliva identification and categorization of genetic variants each comparator genome (eg parent)

Endothelial function assessment using peripheral vascular response to reactive hyperemia non-invasive (eg brachial artery ultrasound peripheral artery tonometry) unilateral or bilateral

Oncology (plasma cell disorders and myeloma) circulating plasma cell immunologic selection identification morphological characterization and enumeration of plasma cells based on differential CD138 CD38 CD19 and CD45 protein biomarker expression peripheral blood

Transcatheter renal sympathetic denervation percutaneous approach including arterial puncture selective catheter placement(s) renal artery(ies) fluoroscopy contrast injection(s) intraprocedural roadmapping and radiological supervision and interpretation including pressure gradient measurements flush aortogram and diagnostic renal angiography when performed; unilateral

Oncology (solid tumor) circulating tumor cell selection identification morphological characterization detection and enumeration based on differential EpCAM cytokeratins 8 18 and 19 and CD45 protein biomarkers and quantification of HER2 protein biomarker-expressing cells peripheral blood

Transcatheter renal sympathetic denervation percutaneous approach including arterial puncture selective catheter placement(s) renal artery(ies) fluoroscopy contrast injection(s) intraprocedural roadmapping and radiological supervision and interpretation including pressure gradient measurements flush aortogram and diagnostic renal angiography when performed; bilateral

Oncology (prostate) mRNA expression profiling of HOXC6 and DLX1 reverse transcription polymerase chain reaction (RT-PCR) first-void urine following digital rectal examination algorithm reported as probability of high-grade cancer

Ablation pulmonary tumor(s) including pleura or chest wall when involved by tumor extension percutaneous cryoablation unilateral includes imaging guidance

Oncology (pan-cancer) analysis of minimal residual disease (MRD) from plasma with assays personalized to each patient based on prior next-generation sequencing of the patient's tumor and germline DNA reported as absence or presence of MRD with disease-burden correlation if appropriate

Quantitative pupillometry with interpretation and report unilateral or bilateral

Fetal aneuploidy DNA sequencing comparative analysis fetal DNA from products of conception reported as normal (euploidy) monosomy trisomy or partial deletion/duplication mosaicism and segmental aneuploid

Therapeutic apheresis with selective HDL delipidation and plasma reinfusion

Oncology (pancreatic cancer) multiplex immunoassay of C5 C4 cystatin C factor B osteoprotegerin (OPG) gelsolin IGFBP3 CA125 and multiplex electrochemiluminescent immunoassay (ECLIA) for CA19-9 serum diagnostic algorithm reported qualitatively as positive negative or borderline

Transcatheter mitral valve repair percutaneous approach including transseptal puncture when performed; initial prosthesis

Oncology (prostate) exosome-based analysis of 442 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction (RT-qPCR) urine reported as molecular evidence of no- low- intermediate- or high-risk of prostate cancer